Related Experiment Videos
Active human immunodeficiency virus protease is required for viral infectivity
N E Kohl1, E A Emini, W A Schleif
1Department of Molecular Biology, Merck Sharp & Dohme Research Laboratories, West Point, PA 19486.
Summary
The human immunodeficiency virus (HIV) protease is essential for viral replication. Mutating a key residue in the HIV protease gene prevents viral maturation and infection, highlighting its potential as a drug target.
Area of Science:
- Virology
- Molecular Biology
- Biochemistry
Background:
- Retroviral proteins are synthesized as polyproteins requiring proteolytic cleavage for maturation.
- The human immunodeficiency virus (HIV) protease plays a critical role in processing these viral polyproteins during replication.
Purpose of the Study:
- To investigate the essential role of the HIV protease in the viral replication cycle.
- To determine the impact of a specific mutation within the HIV protease gene on its enzymatic activity and viral infectivity.
Main Methods:
- Site-directed mutagenesis was used to alter a specific residue (Asp-25 to Asn-25) in the HIV protease gene.
- The mutant HIV protease was expressed in E. coli and its proteolytic activity against HIV gag p55 was assessed in vitro.
- A mutant HIV provirus containing the Asn-25 mutation was constructed and transfected into SW480 cells.
- Virions produced from transfected cells were analyzed for gag protein processing and infectivity against MT-4 lymphoid cells.
Main Results:
- The Asn-25 mutation eliminated the in vitro proteolytic activity of the HIV protease against HIV gag p55.
- Virions produced from cells transfected with the Asn-25 mutant provirus contained uncleaved gag p55, lacking mature gag p24 and gag p17.
- These mutant virions were unable to infect MT-4 lymphoid cells, unlike wild-type virions.
Conclusions:
- The HIV protease is an essential viral enzyme required for the production of infectious virions.
- The specific Asp-25 residue is critical for the protease's enzymatic function.
- The HIV protease represents a promising target for the development of anti-HIV therapeutic drugs.